ticlopidine has been researched along with cilostazol in 193 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.52) | 18.7374 |
| 1990's | 7 (3.63) | 18.2507 |
| 2000's | 62 (32.12) | 29.6817 |
| 2010's | 117 (60.62) | 24.3611 |
| 2020's | 6 (3.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ando, Y; Ikeda, Y; Kikuchi, M; Murakami, H; Murata, M; Satoh, K; Watanabe, K | 1 |
| Obata, Y; Oda, M; Yamamoto, N; Yokota, K | 1 |
| Priollet, P | 1 |
| Hong, MK; Kim, HS; Kim, JJ; Lee, CW; Lee, HJ; Park, HK; Park, SJ; Park, SW | 1 |
| Eto, K; Isshiki, T; Kondo, K; Ochiai, M; Oshima, A; Sato, T; Takeshita, S; Yokoyama, N | 1 |
| Adachi, T; Ishida, K; Ito, R; Kimura, Y; Kohda, N; Marukawa, K; Matsumoto, Y; Nakayama, S; Tani, T | 1 |
| Cho, SY; Jang, Y; Kim, IJ; Lee, DH; Pyun, WB; Shim, WH; Yoon, Y | 1 |
| Mochizuki, Y; Oishi, M; Satoh, Y; Shikata, E | 1 |
| Munakata, A; Nakahata, R; Ono, F; Takami, H; Tamai, Y | 1 |
| Ikeda, Y; Isaka, N; Ito, M; Kitai, T; Makino, K; Nakano, T; Nishikawa, M; Okinaka, T; Shiku, H; Tanigawa, T; Ueda, Y | 1 |
| Hong, MK; Kim, HS; Kim, JJ; Lee, CW; Lee, NH; Nah, DY; Park, SJ; Park, SW | 1 |
| Ayabe, S; Hara, K; Ikari, Y; Kozuma, K; Kuroda, Y; Morino, Y; Tamura, T; Tanabe, K; Yamasaki, M | 1 |
| Hotta, A; Masuda, N; Matsubara, T; Nagaoka, N; Okazaki, K; Shikaura, K | 1 |
| Ito, E; Nakagawa, I; Suzuki, K; Tanabe, Y | 1 |
| Schainfeld, RM | 1 |
| Inoue, T; Kamishirado, H; Mizoguchi, K; Morooka, S; Nakata, T; Sakuma, M; Takayanagi, K; Uchida, T | 1 |
| Silber, S | 1 |
| Olin, JW | 1 |
| Conners, MS; Money, SR | 1 |
| Akimaru, S; Ito, H; Katsube, N; Maegawa, H; Marsala, M; Nakai, K; Takenobu, Y; Takimizu, H | 1 |
| Comerota, AJ; Gaughan, JP; Rao, AK; Schmieder, FA; Throm, RC; Wilhite, DB | 1 |
| Han, KH; Hong, MK; Kang, DH; Kim, JJ; Kim, YH; Lee, CW; Lee, SW; Mintz, GS; Park, SJ; Park, SW; Song, JK; Song, JM | 1 |
| Adachi, H; Hoshizaki, H; Kurabayashi, M; Ohshima, S; Sekiguchi, M; Taniguchi, K | 1 |
| Hashiguchi, M; Kishino, S; Mochizuki, M; Nakazawa, R; Ohno, K; Shiga, T | 1 |
| Kim, JS; Kim, YI; Lee, KS; Nakahata, R; Takami, H; Tamai, Y | 1 |
| Daida, H; Kurata, T; Miyauchi, K; Okazaki, S; Sato, H; Shimada, K; Yokoyama, T | 1 |
| Clagett, GP; Jackson, MR; Lip, GY; Sobel, M; Tangelder, M; Verhaeghe, R | 1 |
| Hikichi, Y; Imoto, Y; Inoue, T; Node, K; Ozaki, Y; Ozeki, Y; Sakuma, M; Uchida, T | 1 |
| Heidenreich, PA; Olkin, I; Schleinitz, MD | 1 |
| Ahn, JC; Kwon, JA; Oh, DJ; Park, CG; Rho, YM; Seo, HS; Song, WH | 1 |
| Beckman, JA; Jaff, MR; Jang, J; Olin, JW; Rooke, T | 1 |
| Han, KH; Hong, MK; Kang, SJ; Kim, JJ; Kim, YH; Lee, CW; Lee, SW; Park, JH; Park, SJ; Park, SW | 1 |
| Adachi, K; Kataoka, T; Kawata, M; Kuramoto, E; Matsuura, A; Saito, A; Sakamoto, S | 1 |
| Fumikura, Y; Ishikawa, K; Noguchi, Y; Takeyasu, N; Watanabe, S; Yamaguchi, I | 1 |
| Massel, D | 1 |
| Comerota, AJ | 1 |
| Han, KH; Hong, MK; Kang, DH; Kim, JJ; Kim, YH; Lee, BK; Lee, CW; Lee, SW; Park, SJ; Park, SW; Song, JK; Song, JM | 1 |
| Deng, J; Ge, JB; Han, YL; Jing, QM; Li, Y; Ma, YY; Wang, SL; Yang, GT; Yu, HB | 1 |
| Iwata, M; Kimura, Y; Nakamura, T; Uchiyama, S; Yamazaki, M | 1 |
| Holmes, DR | 1 |
| Chen, YD; Jin, ZN; Lü, SZ; Lu, YL; Yuan, F | 1 |
| Han, YL; Jing, QM; Li, Y; Luan, B; Ma, YY; Su, QF; Wang, DM; Wang, SL; Wang, ZL | 1 |
| Kreindel, M; Lincoff, AM; Patel, TN | 1 |
| Aruna, D; Naidu, MU | 1 |
| Han, YL; Kang, J; Li, Y; Su, QF; Wang, SL; Yan, CH | 1 |
| Bagga, S; Comerota, AJ; Gaughan, J; Jalagadugula, G; Rao, AK; Vaidyula, VR; Wilhite, DB | 1 |
| Liao, JK | 1 |
| Bhatt, DL; Meadows, TA | 1 |
| Chi, HS; Hong, MK; Jang, S; Kim, JJ; Kim, YH; Lee, BK; Lee, CW; Lee, SW; Park, DW; Park, SJ; Park, SW | 1 |
| Cho, YH; Choi, SW; Chun, KJ; Hong, MK; Kim, HS; Kim, JH; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Seong, IW; Yun, SC | 2 |
| Choi, D; Jang, Y; Jung, JH; Ko, YG; Min, PK; Shim, WH | 1 |
| Ahn, M; Choe, H; Choe, KH; Kim, JY; Lee, K; Lee, SH; Shin, M; Yoo, BS; Yoon, J | 1 |
| Hayashi, K; Hiu, T; Kitagawa, N; Morofuji, Y; Nagata, I; Ochi, A; Suyama, K | 1 |
| Ahn, TH; Ahn, Y; Bae, JH; Chae, IH; Hur, SH; Jeong, JW; Jeong, MH; Kang, WC; Kim, JH; Kim, KH; Kim, KY; Nam, CW; Oh, SK; Park, CG | 1 |
| Kim, S; Lipsitz, EC | 1 |
| Angiolillo, DJ; Aslam, M; Bass, TA; Box, LC; Capranzano, P; Charlton, RK; Desai, B; Goto, S; Guzman, LA; Shoemaker, SB; Suzuki, Y; Zenni, MM | 1 |
| Abe, Y; Endo, H; Fujita, K; Inamori, M; Iwasaki, T; Kirikoshi, H; Kobayashi, N; Kubota, K; Nagashima, Y; Nakajima, A; Nozaki, Y; Saito, S; Takahashi, H; Wada, K; Yoneda, M | 1 |
| Arai, F; Kita, T; Sasaki, S | 1 |
| Kesteven, P; McCaslin, J; Smout, J; Stansby, G | 1 |
| Cho, EJ; Her, SH; Jang, SW; Kim, DB; Kim, JH; Kwon, BJ; Park, CS; Park, HJ; Park, MW; Rho, TH; Shin, D | 1 |
| Amasyali, B; Celik, T; Isik, E; Iyisoy, A; Kilic, A | 1 |
| Ikegami, M; Matsuda, S; Miyashita, Y; Obara, S; Shimizu, M; Sugiyama, N; Takagi, S; Takizawa, S; Yokoyama, J | 1 |
| Choi, BR; Hwang, JY; Jeong, YH; Kim, IS; Kwak, CH; Lee, SW; Park, SW; Seo, MK | 1 |
| Han, Y; Jing, Q; Li, Y; Shu, Q; Tang, X; Wang, D; Wang, S; Wang, Z | 1 |
| Akishita, M; Ako, J; Eto, M; Iijima, K; Ogawa, S; Ota, H; Ouchi, Y | 1 |
| Ahn, YK; Bae, JH; Chae, IH; Chae, JK; Chen, KY; Cho, MC; Choi, DH; Chung, WS; Hong, TJ; Hur, SH; Jang, YS; Jeong, MH; Jin, Z; Kim, CJ; Kim, EJ; Kim, YJ; Li, YJ; Minami, Y; Oh, DJ; Park, CG; Park, SJ; Poddar, KL; Rha, SW; Seo, HS; Seong, IW; Seung, KB; Wang, L; Yoon, JH | 1 |
| Chang, CW; Choi, D; Jang, Y; Kim, JS; Ko, YG; Lee, JE; Lee, JM; Park, S; Shim, CY; Shin, DJ; Shin, ES | 1 |
| Asano, F; Endo, Y; Inoue, K; Sawada, S; Takeyama, Y; Yamada, M; Yasuda, H; Yoshiba, M | 1 |
| Gomez, CR; Qureshi, AI | 1 |
| Hashimoto, A; Ito, H; Matsumoto, Y; Miyakoda, G; Yao, H | 1 |
| Goto, S; Toda, E | 1 |
| Chae, JK; Cho, YH; Choi, SW; Chun, KJ; Hong, MK; Jeong, JO; Jon, S; Kim, HS; Kim, JH; Kim, WJ; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, JY; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Rhee, KS; Seong, IW; Yun, SC | 1 |
| Hwang, JY; Hwang, SJ; Jeong, YH; Kim, IS; Kwak, CH; Lee, SW; Park, SW; Park, Y | 1 |
| Ahluwalia, J; Bhalla, A; Malhotra, S; Pandhi, P; Pattanaik, S; Sharma, YP | 1 |
| Hong, MK; Kim, JJ; Kim, WJ; Kim, YH; Lee, CW; Lee, JY; Lee, SW; Park, DW; Park, SJ; Park, SW; Yun, SC | 1 |
| Croce, K | 1 |
| Ahn, MS; Choe, H; Hong, MK; Kim, JY; Lee, K; Lee, SH; Yoo, BS; Yoon, J | 1 |
| Bae, JH; Bae, JW; Chae, IH; Cho, MC; Choi, DJ; Kang, HJ; Kim, HS; Koo, BK; Kwon, TG; Lee, HY; Lee, SP; Park, KW; Rha, SW; Suh, JW | 1 |
| Diener, HC; Weber, R | 1 |
| Hwang, JY; Hwang, SJ; Jeong, YH; Kang, MK; Kim, IS; Kim, S; Koh, EH; Koh, JS; Kwak, CH; Park, JR; Park, KS; Park, Y | 1 |
| Chu, KM; Han, CL; Lin, GM | 1 |
| Hwang, JY; Hwang, SJ; Jeong, YH; Kang, MK; Kim, IS; Kwak, CH; Park, Y; Yun, SE | 1 |
| Goh, RY; Han, JY; Kim, BR; Kim, JE; Kim, MH; Woo, KS; Yu, LH | 1 |
| Fu, Q; Ishikawa, S; Isshiki, T; Takada, K; Yokoyama, N | 1 |
| Ahn, Y; Cho, JG; Hong, YJ; Jeong, MH; Kang, JC; Kim, JH; Kim, KH; Ko, JS; Lee, MG; Park, HW; Park, JC; Park, KH; Sim, DS; Yoon, HJ; Yoon, NS | 1 |
| Ahn, CM; Hong, SJ; Kim, JS; Lim, DS; Park, JH | 1 |
| Bae, JH; Bae, JW; Chae, IH; Cho, MC; Cho, YS; Choi, DJ; Kang, HJ; Kim, HS; Koo, BK; Kwon, TG; Lee, HY; Lee, SP; Park, KW; Rha, SW; Suh, JW; Youn, TJ | 1 |
| Chae, IH; Cho, YS; Choi, DJ; Kang, HJ; Kim, HS; Koo, BK; Lee, HY; Lee, SP; Oh, BH; Oh, IY; Park, JJ; Park, KW; Park, YB; Suh, JW; Yang, HM; Youn, TJ | 1 |
| Kamal, AK; Khan, M | 1 |
| Bang, DW; Cho, YH; Choi, SW; Choi, YJ; Hyon, MS; Kang, SJ; Kim, HS; Kim, MK; Kim, YH; Lee, BK; Lee, CW; Lee, JH; Lee, K; Lee, NH; Lee, SG; Lee, SJ; Lee, SW; Park, CB; Park, DW; Park, HK; Park, KH; Park, SJ; Park, SW; Park, WJ; Seong, IW; Shin, WY; Yun, SC | 1 |
| Deguchi, I; Dembo, T; Fukuoka, T; Horiuchi, Y; Kato, Y; Maruyama, H; Nagoya, H; Takeda, H; Tanahashi, N | 1 |
| Hwang, JY; Hwang, SJ; Jeong, YH; Kim, IS; Kim, S; Koh, EH; Kwak, CH; Park, JR; Park, KS; Park, Y; Yun, SE | 1 |
| Behr, T; Behr, W; Kuch, B; von Scheidt, W | 1 |
| Easton, JD | 1 |
| Moliterno, DJ; Rajan, L | 1 |
| Angiolillo, DJ; Bass, TA; Box, LC; Capodanno, D; Capranzano, P; Charlton, RK; Darlington, A; Desai, B; Dharmashankar, K; Ferreiro, JL; Guzman, LA; Sumner, S; Ueno, M; Zenni, M | 1 |
| Hirata, K; Momose, A; Nakajima, K; Sasaki, N; Shinohara, M; Takeda, M; Tawa, H; Yamashita, T | 1 |
| Cho, YK; Hong, GR; Hur, SH; Jang, JS; Kim, DI; Kim, DK; Kim, DS; Kim, KB; Kim, U; Kim, YJ; Nam, CW; Park, JS; Seol, SH; Shin, DG; Yang, TH | 1 |
| Angiolillo, DJ; Capodanno, D; Capranzano, P; Desai, B; Ferreiro, JL; Ueno, M | 1 |
| Bae, HJ; Cho, YJ; Han, MK; Hong, KS; Jeong, SW; Kang, DW; Kim, DE; Kim, GM; Kim, HY; Kim, JS; Koo, JS; Kwon, SU; Lee, BC; Lee, JH; Lee, KB; Lee, SH; Lee, YS; Mok, VC; Nah, HW; Park, JM; Rha, JH; Suwanwela, NC; Wong, KS; Yu, KH; Yun, SC | 1 |
| Bae, JH; Bae, JW; Chae, IH; Cho, MC; Kim, HS; Lee, SP; Park, KW; Rha, SW; Suh, JW | 1 |
| Urabe, T | 1 |
| Bliden, KP; Gurbel, PA; Jeong, YH; Tantry, US | 1 |
| Hwang, JY; Hwang, SJ; Jeong, YH; Kim, IS; Kim, S; Koh, EH; Kwak, CH; Kwon, TJ; Park, JR; Park, Y; Yoon, SE | 1 |
| Barakoti, M; Neupane, P; Pant, S; Ramesh, KC | 1 |
| Jung, KH; Kim, W; Kim, WS; Lee, SR; Lee, TW; Lew, JH; Lim, CK; Woo, JS | 1 |
| Angiolillo, DJ; Cequier, AR; Ferreiro, JL | 1 |
| Crea, F; D'Amario, D; Porto, I | 1 |
| Jin, EZ; Li, XQ; Yu, LH | 1 |
| Angiolillo, DJ; Capodanno, D; Capranzano, P; Darlington, A; Desai, B; Dharmashankar, K; Ferreiro, JL; Rollini, F; Tello-Montoliu, A; Ueno, M | 1 |
| Eno, S; Hondo, T; Iwamoto, A; Kimura, M; Matsuda, K; Matsumura, H | 1 |
| Guan, SY; Guo, L; Han, YL; Jing, QM; Li, Y; Liu, XD; Ma, YY; Wang, SL; Wang, XZ; Yang, BS | 1 |
| Abe, K; Deguchi, K; Kawai, H; Kurata, T; Ohta, Y; Omote, Y; Tian, F; Yamashita, T | 1 |
| Asai, T; Haraguchi, K; Izumi, T; Matsubara, N; Miyachi, S; Naito, T; Wakabayashi, T; Yamanouchi, T | 1 |
| He, J; He, Y; Liu, G; Ma, C; Tang, P; Wang, P; Yang, J; Zhou, R; Zhou, S | 1 |
| Hwang, JY; Hwang, SJ; Jeong, YH; Koh, JS; Kwak, CH; Kwon, TJ; Muse, WC; Park, Y | 1 |
| Faircloth, JM; Finks, SW; Rogers, KC | 1 |
| Hanyu, H; Hirao, K; Iwamoto, T; Kanetaka, H; Kume, K; Sakurai, H; Sato, T | 1 |
| Bonneau, HN; Kaneda, H; Koo, BK; Nagai, R; Sakurai, R | 1 |
| Bae, EH; Choi, JS; Choi, YH; Jeong, MH; Kim, CS; Kim, SW; Lim, SY; Ma, SK; Sim, DS; Suh, SH | 1 |
| Cho, KI; Jang, JS; Je, HG; Jeong, YH; Jin, HY; Kim, BH; Kim, DI; Kim, DK; Kim, DS; Kim, WJ; Lee, JY; Lee, SW; Park, YH; Seo, JS; Seol, SH; Yang, TH | 1 |
| Deng, J; Geng, DF; Jin, DM; Liu, M; Wang, JF; Wu, W | 1 |
| Bliden, KP; Gurbel, PA; Hwang, JY; Hwang, SJ; Jeong, YH; Kim, S; Koh, EH; Kwak, CH; Kwon, TJ; Park, JR; Park, Y; Tantry, US | 1 |
| Chang, HW; Chen, YL; Chua, S; Leu, S; Lin, KC; Sheu, JJ; Sun, CK; Tsai, CY; Tsai, TH; Yang, JL; Yen, CH; Yip, HK | 1 |
| Cheong, MA; Kim, DW; Yi, HJ | 1 |
| Choi, KN; Chung, SR; Do, U; Jang, JS; Jin, HY; Kim, DK; Kim, DS; Kim, HJ; Seo, JS; Yang, TH | 1 |
| Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Kim, HJ; Kim, JH; Lee, GY; Lee, SY; Song, YB | 1 |
| Albertal, M; Belardi, JA | 1 |
| Ahn, Y; Cho, JG; Hong, YJ; Jeong, MH; Kang, JC; Kim, JH; Kim, JM; Kim, KH; Lee, KH; Lim, KS; Park, DS; Park, HW; Park, JC; Park, KH; Sim, DS; Yoon, HJ; Yoon, NS | 1 |
| Gao, W; Ge, H; Guo, Y; Zhang, Q; Zhou, Z | 1 |
| Chu, CY; Hsu, PC; Lai, WT; Lee, WH; Lin, TH; Sheu, SH; Su, HM; Voon, WC | 1 |
| Chen, Y; Chen, Z; Ge, J; Ma, J; Qian, J | 1 |
| Aikawa, H; Etou, H; Inoue, R; Kazekawa, K; Kureshima, M; Matsumoto, Y; Narita, S; Nii, K; Sakamoto, K; Tsutsumi, M; Yoshida, H | 1 |
| Fu, ZX; Li, J; Tang, HQ; Zhang, Y | 1 |
| Deguchi, I; Fukuoka, T; Hayashi, T; Horiuchi, Y; Kato, Y; Maruyama, H; Nagoya, H; Ohe, Y; Tanahashi, N | 1 |
| Fujimoto, T; Kono, K; Okada, H; Shintani, A; Tanaka, Y; Terada, T; Tomura, N; Yoshimura, R | 1 |
| Apostolakis, S; Lip, GY; Shantsila, E | 1 |
| Albalbissi, K; Coffey, B; Khosla, S; Molnar, J; Panchal, HB; Patel, P; Ramu, V; Shah, T | 1 |
| Cha, KS; Chae, IH; Hwang, KK; Jeon, HK; Jeong, MH; Kang, HJ; Kang, SH; Kim, HS; Kim, S; Koo, BK; Kwon, HM; Lee, SY; Moon, KW; Oh, JH; Park, BE; Park, JJ; Park, KW; Park, TH; Rhew, JY; Shin, ES; Yang, HM; Yoon, JH | 1 |
| DiNicolantonio, JJ; Lavie, CJ | 1 |
| Ahn, JM; Cho, YR; Han, S; Jang, JY; Kang, SJ; Kim, JJ; Kim, WJ; Kim, YH; Kwon, CH; Lee, CW; Lee, JY; Lee, SW; Lee, WS; Park, DW; Park, GM; Park, SJ; Park, SW; Park, YK | 1 |
| Chen, Y; Huang, X; Tang, Y; Xie, Y; Zhang, Y | 1 |
| Tselepis, AD | 1 |
| Bangalore, S; Dinicolantonio, JJ; Lavie, CJ; Meier, P; Niazi, AK; O'Keefe, JH | 1 |
| Ha, SJ; Hwang, SJ; Kim, KS; Kim, MK; Kim, SJ; Kim, W; Kim, WS; Woo, JS | 1 |
| Kichikawa, K; Nakagawa, H; Nakagawa, I; Nakase, H; Nishimura, F; Park, HS; Wada, T; Yamada, S | 1 |
| Abe, K; Deguchi, K; Ikeda, Y; Kono, S; Kurata, T; Liu, N; Liu, W; Omote, Y; Yamashita, T | 1 |
| Inuyama, L; Mizuno, O; Sakaguchi, T; Takahashi, S; Yamada, T | 1 |
| Ahn, SG; Choi, H; Hong, MK; Hong, YJ; Jang, Y; Kwon, HM; Lee, JW; Lee, SH; Yoon, J; Youn, YJ; Yu, CW | 1 |
| Inoue, Y; Ishii, H; Jinno, Y; Murohara, T; Okada, K; Okumura, S; Sakakibara, M; Suzuki, S; Tanaka, A | 1 |
| Ezura, M; Hyodo, A; Matsubara, Y; Matsumaru, Y; Matsumoto, Y; Miyachi, S; Nakamura, M; Okada, Y; Sakai, C; Sakai, N; Terada, T; Yamagami, H; Yokoi, H | 1 |
| Adamson, P; Cruden, NL | 1 |
| Kang, W; Kwon, KI; Lee, BY; Park, S; Yeul Ma, J; Yoon, YR; Yun, HY | 1 |
| Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Jang, Y; Kim, HS; Lee, SH; Oh, JH; Seung, KB; Song, PS; Song, YB; Yang, JH | 1 |
| Cho, SY; Gurbel, PA; Hwang, JY; Hwang, SJ; Jeong, YH; Kim, IS; Koh, JS; Kwak, CH; Lee, EJ; Park, JR; Park, Y; Tantry, US; Yoon, SE | 1 |
| Chai, HT; Chang, HW; Chen, CH; Chen, YC; Chen, YL; Chua, S; Chung, SY; Ko, SF; Leu, S; Lin, PY; Sheu, JJ; Sung, PH; Tsai, TH; Yip, HK | 1 |
| Yamamoto, Y | 1 |
| Spiliopoulos, S | 1 |
| Bai, J; Chen, J; Chen, P; Eikelboom, JW; Gong, X; Kong, D; Li, C; Liu, J; Meng, H; Xu, L; Yang, Z; Zou, F | 1 |
| Gurbel, PA; Hwang, JY; Hwang, SJ; Jeong, YH; Jung, JM; Kim, K; Kim, S; Koh, JS; Kwak, CH; Park, JR; Park, Y; Tantry, US | 1 |
| Izuhara, C; Takayama, S; Takeuchi, K | 1 |
| Cafaro, G; de Gaetano, G; Di Minno, A; Di Minno, G; Lupoli, R; Petitto, M; Spadarella, G; Tremoli, E | 1 |
| Bae, JH; Baek, JY; Bong, JM; Cho, JH; Cho, YH; Choi, CU; Choi, HJ; Choi, SH; Choi, WG; Chung, WY; Her, SH; Kang, WY; Kim, EJ; Kim, JH; Kim, KC; Kim, MW; Kim, SM; Kim, WH; Kim, YH; Kim, YJ; Lee, SJ; Oh, DJ; Park, MW; Park, SH; Rha, SW; Seo, JB; Soh, JW; Suh, J | 1 |
| Hoshino, H; Kimura, K; Minematsu, K; Naritomi, H; Origasa, H; Toyoda, K; Uchiyama, S; Yamaguchi, T | 1 |
| Hayashi, K; Horie, N; Izumo, T; Kaminogo, M; Nagata, I; Tsujino, A | 1 |
| Che, JJ; Chen, KY; Li, GP; Liu, T; Rha, SW; Xu, LX; Zheng, XT | 1 |
| Ghim, JL; Kim, DH; Kim, EY; Kim, HS; Lim, Y; Oh, M; Shin, JG | 1 |
| Bundhun, PK; Chen, MH; Qin, T | 1 |
| Hironaka, Y; Kichikawa, K; Motoyama, Y; Nakagawa, I; Nakase, H; Park, HS; Takayama, K; Wada, T; Yokoyama, S | 1 |
| Chang, K; Choi, YS; Chung, WB; Chung, WS; Kim, HY; Kim, JY; Kwon, A; Lee, MY; Park, CS; Seung, KB | 1 |
| Bae, SK; Kim, GJ; Kim, JH; Lee, J; Lee, S; Lim, HS; Noh, Y; Oh, E; Shin, S | 1 |
| Guo, ZN; Jin, H; Niu, PP; Xing, YQ; Yang, Y | 1 |
| Kataoka, Y; Nakagawa, A; Otoshi, T; Otsuka, K; Tomii, K | 1 |
| Chen, KY; Jiao, ZQ; Li, G; Liu, T; Xu, LX; Xu, Y; Zheng, XT | 1 |
| Abizaid, A; Costa, JR; Costa, R; Feres, F; Mangione, JA; Piva E Mattos, LA; Siqueira, D; Sousa, A; Staico, R; Zuliani Mauro, MF | 1 |
| Kichikawa, K; Motoyama, Y; Nakagawa, I; Nakase, H; Park, HS; Wada, T; Yamada, S; Yokoyama, S | 1 |
| Jang, HJ; Kang, WC; Kim, TH; Kwon, SW; Lee, K; Moon, J; Oh, PC; Park, HW; Park, SD; Suh, J | 1 |
| Abramenko, AV; Bytsay, AN; Lysak, LI; Nikuhinikov, PI; Yatsenko, AI | 1 |
| Cheng, JH; Feng, ZW; Hu, ZH; Li, XY; Lv, QZ; Shi, HT; Wang, QB; Wang, Z; Wu, HY; Xie, XQ; Xu, Q; Xue, Y | 1 |
| Duconge, J; Garcia, MJ; Hernandez-Suarez, DF; Lopez-Candales, A; Marshall, L; Melin, K; Nieves-Borrero, K; Núñez-Medina, H; Rodriguez-Ruiz, C; Scott, SA; Wiley, JM | 1 |
| Liu, X; Zhang, JJ | 1 |
| Jiang, WJ; Li, C; Liu, AF; Qiu, H; Wang, K; Wu, Z; Zhang, Y; Zhou, J | 1 |
| Chiba, T; Fujimoto, K; Fujiwara, S; Kobayashi, M; Kubo, Y; Ogasawara, K; Setta, K; Shimada, Y; Terasaki, K; Tsutsui, S; Yoshida, J; Yoshida, K | 1 |
| Hankey, GJ | 1 |
| Ji, RJ; Lin, YJ; Yuan, HW | 1 |
| de Havenon, A; Kraler, L; Lansberg, MG; Zhou, LW | 1 |
| Cheng, Y; Li, D; Liu, H; Shao, T; Wang, H; Yang, T; Zhang, J; Zhang, T | 1 |
| Cha, JJ; Chae, IH; Cho, JY; Choi, SH; Hong, SJ; Joo, HJ; Kim, JH; Ko, YG; Koh, YS; Kook, H; Lee, JH; Lee, SH; Lee, SR; Lee, SW; Lim, DS; Lim, S; Min, PK; Park, JH; Yoon, CH; Yu, CW | 1 |
| Dahlen, JR; Hosokawa, K; Kitagawa, K; Ohnishi, T; Shirai, Y; Yamazaki, M | 1 |
39 review(s) available for ticlopidine and cilostazol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Arteriopathy of the lower limbs: toward a global medical care].
Topics: Angiography; Arterial Occlusive Diseases; Arteriosclerosis; Cilostazol; Clinical Trials as Topic; Clopidogrel; Endothelial Growth Factors; Genetic Therapy; Humans; Iloprost; Leg; Lymphokines; Multicenter Studies as Topic; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Protein Isoforms; Randomized Controlled Trials as Topic; Tetrazoles; Ticlopidine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilator Agents | 1999 |
What can I do to continue walking despite intermittent claudication?
Topics: Aspirin; Cilostazol; Clopidogrel; Humans; Intermittent Claudication; Tetrazoles; Ticlopidine; Vasodilator Agents; Walking | 2001 |
Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature.
Topics: Animals; Blood Vessels; Brachytherapy; Cilostazol; Clopidogrel; Constriction, Pathologic; Drug Delivery Systems; Endothelium, Vascular; Genetic Therapy; Heparin, Low-Molecular-Weight; Humans; Plastic Surgery Procedures; Platelet Aggregation Inhibitors; Probucol; Stents; Tetrazoles; Ticlopidine; Vasodilation; Vasodilator Agents | 2002 |
[Antiproliferative coated stents and intracoronary brachytherapy: common traits and differences].
Topics: Brachytherapy; Cell Division; Cilostazol; Clinical Trials as Topic; Clopidogrel; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Humans; Platelet Aggregation; Tetrazoles; Ticlopidine; Treatment Outcome | 2002 |
Management of patients with intermittent claudication.
Topics: Aspirin; Blood Vessel Prosthesis; Cilostazol; Clopidogrel; Exercise Therapy; Humans; Intermittent Claudication; Medical History Taking; Pentoxifylline; Physical Examination; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Vasodilator Agents | 2002 |
Can claudication be improved with medication?
Topics: Carnitine; Cilostazol; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Platelet Aggregation Inhibitors; Prostaglandins; Tetrazoles; Ticlopidine; Vasodilator Agents | 2002 |
Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting.
Topics: Administration, Oral; Aspirin; Cilostazol; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Data Collection; Data Interpretation, Statistical; Death; Documentation; Drug Administration Schedule; Drug Therapy, Combination; Elective Surgical Procedures; Evaluation Studies as Topic; Humans; Japan; Medical Records; Myocardial Infarction; Odds Ratio; Stents; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2004 |
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Arterial Occlusive Diseases; Aspirin; Cilostazol; Clopidogrel; Contraindications; Evidence-Based Medicine; Extremities; Fibrinolytic Agents; Heparin; Humans; Intermittent Claudication; Ischemia; Randomized Controlled Trials as Topic; Risk Assessment; Tetrazoles; Thromboembolism; Ticlopidine; Vitamin K | 2004 |
Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials.
Topics: Anticoagulants; Aspirin; Cilostazol; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Tetrazoles; Ticlopidine; Warfarin | 2004 |
The top 12 advances in vascular medicine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cilostazol; Clopidogrel; Factor V; Heparin, Low-Molecular-Weight; Hot Temperature; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic Syndrome; Mutation; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Platelet Aggregation Inhibitors; Purines; Sildenafil Citrate; Sulfones; Tetrazoles; Thrombin; Ticlopidine; Vascular Diseases; Vascular Surgical Procedures | 2004 |
Effect on platelet function of cilostazol, clopidogrel, and aspirin, each alone or in combination.
Topics: Aspirin; Bleeding Time; Blood Platelets; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Intermittent Claudication; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome | 2005 |
Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
Topics: Aspirin; Atherosclerosis; Cilostazol; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Dipyridamole; Disease Susceptibility; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Hemorrhage; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Vasodilator Agents | 2007 |
Clinical aspects of platelet inhibitors and thrombus formation.
Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Pentanoic Acids; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, PAR-1; Stents; Tetrazoles; Thrombosis; Thromboxanes; Ticlopidine | 2007 |
Oral antiplatelet agents and bleeding risk in relation to major cardiovascular surgery.
Topics: Aspirin; Cardiovascular Surgical Procedures; Cilostazol; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk; Tetrazoles; Ticlopidine | 2006 |
Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention.
Topics: Aspirin; Blood-Brain Barrier; Cilostazol; Clopidogrel; Dipyridamole; Drug Interactions; Drug Therapy, Combination; Humans; Lactones; Naphthalenes; Platelet Aggregation Inhibitors; Propionates; Pyridines; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Succinates; Tetrazoles; Thrombosis; Ticlopidine | 2010 |
Antithrombotic management for transient ischemic attack and ischemic stroke (other than atrial fibrillation).
Topics: Adenosine; Aryl Hydrocarbon Hydroxylases; Brain Ischemia; Cilostazol; Clinical Trials as Topic; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Fibrinolytic Agents; Foramen Ovale, Patent; Genotype; Humans; Ischemic Attack, Transient; Piperazines; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prasugrel Hydrochloride; Risk Assessment; Risk Factors; Stroke; Tetrazoles; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS?
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Quinazolinones; Receptors, Purinergic P2Y12; Sulfonamides; Tetrazoles; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
[New clinical concept and therapeutic strategy for TIA].
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Diffusion Magnetic Resonance Imaging; Humans; Ischemic Attack, Transient; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk; Secondary Prevention; Stroke; Tetrazoles; Ticlopidine; Time Factors | 2010 |
Oral antiplatelet therapy in patients with diabetes mellitus and acute coronary syndromes.
Topics: Acute Coronary Syndrome; Administration, Oral; Aspirin; Cilostazol; Clopidogrel; Diabetes Complications; Humans; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome | 2010 |
Cilostazol and primary-PCI: mirage or good alternative?
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; Aspirin; Cilostazol; Clopidogrel; Combined Modality Therapy; Coronary Restenosis; Drug Therapy, Combination; Heart Failure; Humans; Phosphodiesterase 3 Inhibitors; Platelet Aggregation Inhibitors; Prodrugs; Risk; Stents; Tetrazoles; Thrombosis; Ticlopidine | 2012 |
The effectiveness and safety of triple-antiplatelet treatment based on cilostazol for patients receiving percutaneous coronary intervention: a meta-analysis.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Confidence Intervals; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine | 2012 |
Use of cilostazol in percutaneous coronary interventions.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Phosphodiesterase 3 Inhibitors; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Vasodilator Agents | 2012 |
Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: a meta-analysis of randomized controlled trials.
Topics: Aspirin; Cardiovascular Diseases; Cilostazol; Clopidogrel; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Tetrazoles; Ticlopidine | 2013 |
A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation.
Topics: Aspirin; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cilostazol; Clopidogrel; Combined Modality Therapy; Coronary Restenosis; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 2012 |
Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5,821 patients.
Topics: Acute Coronary Syndrome; Aspirin; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cilostazol; Clopidogrel; Coronary Restenosis; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome | 2012 |
Addition of cilostazol to conventional dual antiplatelet therapy reduces the risk of cardiac events and restenosis after drug-eluting stent implantation: a meta-analysis.
Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heart Diseases; Humans; Male; Middle Aged; Myocardial Revascularization; Odds Ratio; Platelet Aggregation Inhibitors; Risk; Tetrazoles; Ticlopidine | 2013 |
Efficacy and safety of triple-antiplatelet therapy after percutaneous coronary intervention: a meta-analysis.
Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Publication Bias; Stents; Tetrazoles; Ticlopidine | 2013 |
Pharmacokinetic considerations for antithrombotic therapies in stroke.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Cilostazol; Clopidogrel; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Stroke; Tetrazoles; Thiophenes; Thrombin; Ticlopidine; Vitamin K | 2013 |
Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysis.
Topics: Aspirin; Blood Platelets; Cilostazol; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Thromboembolism; Ticlopidine | 2013 |
Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons.
Topics: Aspirin; Cilostazol; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome | 2014 |
Triple versus dual antiplatelet therapy in acute coronary syndromes: adding cilostazol to aspirin and clopidogrel?
Topics: Acute Coronary Syndrome; Aspirin; Cilostazol; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Phosphodiesterase 3 Inhibitors; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine | 2013 |
[Concept, pathophysiology and treatment for branch atheromatous disease].
Topics: Antipyrine; Arginine; Cerebral Infarction; Cilostazol; Clopidogrel; Contraindications; Drug Therapy, Combination; Edaravone; Humans; Magnetic Resonance Imaging; Pipecolic Acids; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Sulfonamides; Tetrazoles; Ticlopidine; Tissue Plasminogen Activator | 2014 |
Antiplatelet therapy in critical limb ischemia: update on clopidogrel and cilostazol.
Topics: Cilostazol; Clopidogrel; Combined Modality Therapy; Critical Illness; Drug Therapy, Combination; Endovascular Procedures; Humans; Ischemia; Lower Extremity; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Risk Factors; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 2014 |
Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials.
Topics: Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Stroke; Tetrazoles; Thrombosis; Ticlopidine | 2015 |
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease.
Topics: Adenosine; Aspirin; Asymptomatic Diseases; Cilostazol; Clopidogrel; Fibrinolytic Agents; Humans; Intermittent Claudication; Ischemia; Lower Extremity; Meta-Analysis as Topic; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Primary Prevention; Review Literature as Topic; Secondary Prevention; Stroke; Tetrazoles; Thrombosis; Ticagrelor; Ticlopidine | 2014 |
Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials.
Topics: Acute Coronary Syndrome; Aspirin; Cilostazol; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Thrombosis; Ticlopidine | 2015 |
Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Topics: Aspirin; Cilostazol; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Tetrazoles; Ticlopidine | 2016 |
Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction.
Topics: Aspirin; Cerebral Infarction; Cilostazol; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hematologic Agents; Humans; Intracranial Hemorrhages; Tetrazoles; Ticlopidine; Warfarin | 2018 |
74 trial(s) available for ticlopidine and cilostazol
| Article | Year |
|---|---|
Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo. Randomized, double-blind cross-over study.
Topics: Aged; Aspirin; Azoles; beta-Thromboglobulin; Blood Platelets; Cilostazol; Double-Blind Method; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Factor 4; Random Allocation; Tetrazoles; Ticlopidine | 1987 |
Comparison of cilostazol versus ticlopidine therapy after stent implantation.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 1999 |
Impact of cilostazol on clinical and angiographic outcome after primary stenting for acute myocardial infarction.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Coronary Angiography; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Premedication; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 1999 |
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Cilostazol; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Survival Rate; Tetrazoles; Ticlopidine; Treatment Outcome | 1999 |
Increased platelet aggregability in response to shear stress in acute myocardial infarction and its inhibition by combined therapy with aspirin and cilostazol after coronary intervention.
Topics: Aged; Aspirin; Cilostazol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; von Willebrand Factor | 2000 |
Effects of cilostazol on angiographic restenosis after coronary stent placement.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Coronary Angiography; Coronary Disease; Disease-Free Survival; Drug Therapy, Combination; Follow-Up Studies; Humans; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Recurrence; Stents; Tetrazoles; Ticlopidine | 2000 |
Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation.
Topics: Cilostazol; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Regression Analysis; Stents; Tetrazoles; Ticlopidine; Time Factors | 2001 |
Comparison of ticlopidine and cilostazol for the prevention of restenosis after percutaneous transluminal coronary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Cilostazol; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Tetrazoles; Ticlopidine | 2001 |
Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
Topics: Aged; Aspirin; Cilostazol; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Care; Prospective Studies; Research Design; Stents; Tetrazoles; Ticlopidine | 2002 |
Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Bleeding Time; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Humans; Intermittent Claudication; Leg; Male; Platelet Aggregation Inhibitors; Prospective Studies; Tetrazoles; Ticlopidine | 2003 |
Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: a randomized comparison of ticlopidine and cilostazol.
Topics: Aged; Cilostazol; Coronary Restenosis; Coronary Stenosis; Equipment Design; Female; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Ticlopidine; Time Factors | 2004 |
Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting.
Topics: Administration, Oral; Aspirin; Cilostazol; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Data Collection; Data Interpretation, Statistical; Death; Documentation; Drug Administration Schedule; Drug Therapy, Combination; Elective Surgical Procedures; Evaluation Studies as Topic; Humans; Japan; Medical Records; Myocardial Infarction; Odds Ratio; Stents; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2004 |
A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls: analysis with quantitative bleeding time and platelet aggregation test.
Topics: Adult; Aspirin; Bleeding Time; Cilostazol; Clopidogrel; Cross-Over Studies; Double-Blind Method; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Tetrazoles; Ticlopidine; Time Factors | 2004 |
Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atorvastatin; Cardiovascular Agents; Cholesterol, LDL; Cilostazol; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Heparin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Tetrazoles; Ticlopidine; Treatment Outcome; Ultrasonography, Interventional | 2004 |
Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aged; Cilostazol; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Cyclic Nucleotide Phosphodiesterases, Type 3; Female; Flow Cytometry; Humans; Leukocytes; Macrophage-1 Antigen; Male; Middle Aged; Neutrophils; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Research Design; Stents; Tetrazoles; Ticlopidine | 2004 |
Comparison of cilostazol and clopidogrel after successful coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Restenosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome | 2005 |
Comparative inhibitory effects of cilostazol and ticlopidine on subacute stent thrombosis and platelet function in acute myocardial infarction patients with percutaneous coronary intervention.
Topics: Aged; Aspirin; Cilostazol; Drug Therapy, Combination; Female; Humans; Incidence; Male; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Retrospective Studies; Stents; Tetrazoles; Thrombosis; Ticlopidine | 2005 |
Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting.
Topics: Aged; Cilostazol; Coronary Disease; Double-Blind Method; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Ticlopidine | 2005 |
[Effects of cilostazol on long-term clinical outcomes after coronary stenting].
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Coronary Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 2005 |
A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent.
Topics: Adult; Aged; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Ticlopidine | 2006 |
[Short-term outcomes of triple antiplatelet therapy after percutaneous coronary intervention].
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Period; Retrospective Studies; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2006 |
Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects.
Topics: Cilostazol; Clopidogrel; Cross-Over Studies; Ginkgo biloba; Herb-Drug Interactions; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Tetrazoles; Ticlopidine | 2007 |
[The effects of post coronary stenting triple antiplatelet therapies on platelet functions].
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Coronary Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Ticlopidine | 2006 |
Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Antithrombin III; Aspirin; Blood Platelets; C-Reactive Protein; CD40 Ligand; Cell Membrane; Cilostazol; Clopidogrel; Down-Regulation; Drug Therapy, Combination; Factor VIIa; Humans; Middle Aged; P-Selectin; Peptide Fragments; Peptide Hydrolases; Peripheral Vascular Diseases; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Prothrombin; Tetrazoles; Thromboplastin; Ticlopidine | 2006 |
Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
Topics: Aspirin; Biomarkers; Blood Vessel Prosthesis Implantation; Cilostazol; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Drug Therapy, Combination; Female; Flow Cytometry; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Revascularization; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Preoperative Care; Radiography; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 2007 |
Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial).
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug Delivery Systems; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome; Tunica Intima | 2007 |
Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study.
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Vessels; Drug Therapy, Combination; Female; Humans; Hyperplasia; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Ticlopidine; Tunica Intima; Ultrasonography, Interventional | 2007 |
Cilostazol could ameliorate platelet responsiveness to clopidogrel in patients undergoing primary percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Blood Platelets; CD40 Antigens; Cilostazol; Clopidogrel; Combined Modality Therapy; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome | 2007 |
Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial.
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Diabetes Complications; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Male; Middle Aged; Tetrazoles; Ticlopidine; Treatment Outcome | 2008 |
Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Im
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Diabetes Mellitus; Diabetic Angiopathies; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome; Tunica Intima | 2008 |
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Tetrazoles; Ticlopidine; Treatment Outcome | 2008 |
Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients W
Topics: Cilostazol; Clopidogrel; Coronary Disease; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Ticlopidine | 2009 |
Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Radiography; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome; Young Adult | 2009 |
Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans.
Topics: Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Cilostazol; Clopidogrel; Confidence Intervals; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Drug Resistance; Female; Humans; Korea; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Tetrazoles; Ticlopidine | 2009 |
Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Restenosis; Diabetes Complications; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome | 2010 |
Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patie
Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; Blood Vessel Prosthesis Implantation; Cells, Cultured; Chemotherapy, Adjuvant; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Ticlopidine | 2010 |
Effect of cilostazol on platelet aggregation in patients with non-ST elevation acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine | 2010 |
Cilostazol augments the inhibition of platelet aggregation in clopidogrel low-responders.
Topics: Blood Platelets; Cilostazol; Clopidogrel; Drug Synergism; Drug-Eluting Stents; Humans; Platelet Aggregation; Platelet Function Tests; Prospective Studies; Receptors, Purinergic P2Y12; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vas
Topics: Angioplasty, Balloon, Coronary; Aspirin; Brain Ischemia; Cilostazol; Clinical Protocols; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Republic of Korea; Research Design; Stroke; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
Cytochrome 2C19 polymorphism and response to adjunctive cilostazol versus high maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention.
Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Blood Platelets; Chemotherapy, Adjuvant; Cilostazol; Clopidogrel; Codon, Nonsense; Cytochrome P-450 CYP2C19; DNA Mutational Analysis; Humans; Ischemia; Platelet Aggregation; Polymorphism, Genetic; Receptors, Purinergic P2Y12; Tetrazoles; Ticlopidine | 2010 |
Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Aspirin; Carotid Arteries; Carotid Stenosis; Chi-Square Distribution; Cilostazol; Clopidogrel; Coronary Angiography; Disease Progression; Drug Therapy, Combination; Hemorrhage; Humans; Inflammation Mediators; Middle Aged; Phosphodiesterase 3 Inhibitors; Platelet Aggregation Inhibitors; Prospective Studies; Republic of Korea; Risk Assessment; Risk Factors; Single-Blind Method; Stents; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography | 2011 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Tetrazoles; Ticlopidine; Treatment Outcome | 2011 |
Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial.
Topics: Aged; Alleles; Aryl Hydrocarbon Hydroxylases; Aspirin; Cardiovascular Diseases; Cilostazol; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Drug-Eluting Stents; Epidemiologic Methods; Female; Humans; Korea; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Tetrazoles; Ticlopidine; Treatment Outcome | 2011 |
A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Sten
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Radiography; Tetrazoles; Ticlopidine; Treatment Outcome | 2011 |
Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Aspirin; Chi-Square Distribution; Cilostazol; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Humans; Korea; Liver; Male; Middle Aged; Myocardial Infarction; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Regression Analysis; Risk Assessment; Risk Factors; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome | 2011 |
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy.
Topics: Aged; Aspirin; Blood Platelets; Chemotherapy, Adjuvant; Cilostazol; Clopidogrel; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Receptors, Purinergic P2Y12; Signal Transduction; Tetrazoles; Thrombin; Ticlopidine | 2011 |
Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis.
Topics: Aged; Aged, 80 and over; Cilostazol; Clopidogrel; Constriction, Pathologic; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intracranial Arteriosclerosis; Ischemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome | 2011 |
Inhibitory interaction between calcium channel blocker and clopidogrel. -Efficacy of cilostazol to overcome it-.
Topics: Aged; Brain Ischemia; Calcium Channel Blockers; Cilostazol; Clopidogrel; Death; Drug Antagonism; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Tetrazoles; Ticlopidine | 2011 |
Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: results of the effect of platelet inhibition according to clopidogrel dose in patients with chronic kidney di
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Cilostazol; Clopidogrel; Coronary Artery Disease; Female; Humans; Kidney Diseases; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Renal Dialysis; Tetrazoles; Ticlopidine | 2011 |
Loading effect of 200 mg cilostazol on platelet inhibition in patients undergoing percutaneous coronary intervention.
Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Endovascular Procedures; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Tetrazoles; Ticlopidine | 2012 |
Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status.
Topics: Aged; Aspirin; Blood Platelets; Cilostazol; Clopidogrel; Coronary Artery Disease; Cross-Over Studies; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Radiography; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Tetrazoles; Ticlopidine; Treatment Outcome | 2013 |
[Effects of intensive antiplatelet therapy for patients with high on-treatment platelet reactivity after coronary stent implantation].
Topics: Acute Coronary Syndrome; Adult; Aged; Aspirin; Blood Platelets; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine | 2012 |
Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspirin; Cerebrovascular Circulation; Cerebrovascular Disorders; Cilostazol; Clopidogrel; Cognition; Female; Humans; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Platelet Aggregation Inhibitors; Prospective Studies; Statistics, Nonparametric; Tetrazoles; Ticlopidine; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Triple vs. dual antiplatelet therapy in patients with acute myocardial infarction and renal dysfunction.
Topics: Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Survival Rate; Tetrazoles; Ticlopidine | 2012 |
Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI.
Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Point-of-Care Systems; Prasugrel Hydrochloride; Prospective Studies; Receptors, Purinergic P2Y12; Tetrazoles; Thiophenes; Ticlopidine | 2013 |
Adjunctive cilostazol versus high maintenance dose of clopidogrel in patients with hyporesponsiveness to chronic clopidogrel therapy.
Topics: Adult; Aged; Blood Platelets; Cilostazol; Clopidogrel; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Purinergic P2Y12; Tetrazoles; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Efficacy and safety of triple antiplatelet therapy in obese patients undergoing stent implantation.
Topics: Adult; Aged; Aspirin; Blood Platelets; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obesity; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Implantation; Stents; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome | 2013 |
Addition of cilostazol to conventional dual antiplatelet therapy reduces the risk of cardiac events and restenosis after drug-eluting stent implantation: a meta-analysis.
Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heart Diseases; Humans; Male; Middle Aged; Myocardial Revascularization; Odds Ratio; Platelet Aggregation Inhibitors; Risk; Tetrazoles; Ticlopidine | 2013 |
Cilostazol reduces periprocedural hemodynamic depression in carotid artery stenting.
Topics: Aged; Angioplasty; Bradycardia; Carotid Stenosis; Cilostazol; Clopidogrel; Female; Humans; Hypotension; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Ticlopidine | 2013 |
Dual antiplatelet therapy clopidogrel with low-dose cilostazol intensifies platelet inhibition in patients with ischemic stroke.
Topics: Adenosine Diphosphate; Aged; Aryl Hydrocarbon Hydroxylases; Brain Ischemia; Cilostazol; Clopidogrel; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2Y12; Risk Factors; Tetrazoles; Ticlopidine | 2013 |
Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-plate
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Factors; Stroke; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Comparison of dual versus triple antiplatelet therapy after drug-eluting stent according to stent length (from the pooled analysis of DECLARE trials).
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Diabetes Complications; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Implantation; Tetrazoles; Ticlopidine; Treatment Outcome | 2013 |
Effect of cilostazol addition or clopidogrel doubling on platelet function profiles in diabetic patients undergoing a percutaneous coronary intervention.
Topics: Blood Platelets; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Resistance; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Republic of Korea; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Multicenter randomized trial of 3-month cilostazol use in addition to dual antiplatelet therapy after biolimus-eluting stent implantation for long or multivessel coronary artery disease.
Topics: Aged; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2014 |
Pharmacodynamic efficacy and safety of adjunctive cilostazol loading to clopidogrel and aspirin loading: the results of the ACCEL-LOADING (Accelerated Platelet Inhibition by Cilostazol Loading) study.
Topics: Aspirin; Cilostazol; Clopidogrel; Cross-Over Studies; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Prospective Studies; Tetrazoles; Ticlopidine | 2014 |
Pharmacodynamic effects of cilostazol versus clopidogrel in stented patients under proton pump inhibitor co-administration: the ACCEL-PARAZOL study.
Topics: Cardiovascular Diseases; Cilostazol; Clopidogrel; Female; Follow-Up Studies; Humans; Lansoprazole; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prognosis; Prospective Studies; Proton Pump Inhibitors; Renal Insufficiency, Chronic; Stents; Tetrazoles; Ticlopidine | 2014 |
Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.
Topics: Alloys; Angioplasty, Balloon; Aspirin; Cilostazol; Clinical Protocols; Clopidogrel; Drug Therapy, Combination; Femoral Artery; Humans; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Popliteal Artery; Prospective Studies; Prosthesis Design; Prosthesis Failure; Research Design; Stents; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency | 2014 |
Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Phosphodiesterase 3 Inhibitors; Platelet Aggregation Inhibitors; Recurrence; Research Design; Stroke; Tetrazoles; Ticlopidine | 2015 |
The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes.
Topics: Administration, Oral; Adult; Area Under Curve; Cilostazol; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Young Adult | 2016 |
Adjunctive loading dose of cilostazol in preventing periprocedural myocardial infarction.
Topics: Aged; Aspirin; Biomarkers; Chi-Square Distribution; China; Cilostazol; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Incidence; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients.
Topics: Aspirin; Cilostazol; Clopidogrel; Comorbidity; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Sirolimus; Tetrazoles; Ticlopidine; Treatment Outcome | 2017 |
Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Stroke; Tetrazoles; Ticlopidine | 2017 |
Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel therapy.
Topics: Aged; Aryldialkylphosphatase; ATP Binding Cassette Transporter, Subfamily B; Blood Platelets; Cilostazol; Clopidogrel; Cross-Sectional Studies; Cytochrome P-450 CYP2C19; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Peripheral Arterial Disease; Pilot Projects; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptors, Purinergic P2Y12; Tetrazoles; Ticlopidine | 2018 |
82 other study(ies) available for ticlopidine and cilostazol
| Article | Year |
|---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Inhibitory effects of the new anti-platelet agent KBT-3022 and its metabolite on rabbit neutrophil function in vitro.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Binding Sites; Calcium; Cell Adhesion; Cilostazol; Complement C3-C5 Convertases; Complement C5a; Cyclooxygenase Inhibitors; Indomethacin; Leukotriene B4; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyrroles; Rabbits; Structure-Activity Relationship; Superoxides; Tetradecanoylphorbol Acetate; Tetrazoles; Thiazoles; Ticlopidine | 1996 |
Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Carotid Arteries; Cilostazol; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Electric Stimulation; Endothelium, Vascular; Hemodynamics; Male; Orchiectomy; Platelet Aggregation; Serotonin; Swine; Tetrazoles; Thrombosis; Thromboxane B2; Ticlopidine | 1999 |
Effect of cilostazol on cerebral blood flows in chronic stage of cerebral circulation.
Topics: Aged; Carotid Arteries; Cerebral Infarction; Cerebrovascular Circulation; Chronic Disease; Cilostazol; Female; Humans; Male; Middle Aged; Tetrazoles; Ticlopidine; Tomography, Emission-Computed, Single-Photon; Ultrasonography; Vasodilator Agents | 2000 |
Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemostasis using a quantitative bleeding time test apparatus.
Topics: Adult; Aspirin; Bleeding Time; Cilostazol; Fibrinolytic Agents; Gastrointestinal Diseases; Headache; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine | 1999 |
Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Coronary Disease; Drug Therapy, Combination; Female; Humans; Japan; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Recurrence; Retrospective Studies; Stents; Tetrazoles; Ticlopidine | 2001 |
Effects of OP-1206 alpha-CD on walking dysfunction in the rat neuropathic intermittent claudication model: comparison with nifedipine, ticlopidine and cilostazol.
Topics: Alprostadil; Animals; Body Weight; Cilostazol; Disease Models, Animal; Exercise Test; Intermittent Claudication; Male; Nifedipine; Platelet Aggregation; Rats; Rats, Wistar; Skin; Spinal Cord; Tetrazoles; Ticlopidine; Time Factors; Walking | 2003 |
Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation.
Topics: Aged; Aspirin; Atherectomy, Coronary; Catheterization; Cilostazol; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Death, Sudden, Cardiac; Disease-Free Survival; Elective Surgical Procedures; Female; Follow-Up Studies; Foreign-Body Migration; Humans; Incidence; Korea; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Stents; Tetrazoles; Ticlopidine; Treatment Outcome; Ultrasonography, Interventional | 2004 |
Effects of cilostazol on platelet activation in coronary stenting patients who already treated with aspirin and clopidogrel.
Topics: Aspirin; Cilostazol; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Ischemia; P-Selectin; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tetrazoles; Thrombosis; Ticlopidine | 2004 |
P >0.05 not equal equivalent or noninferior.
Topics: Angioplasty, Balloon, Coronary; Cilostazol; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Research Design; Stents; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome | 2005 |
Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.
Topics: Aspirin; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Thrombosis; Ticlopidine | 2005 |
New modalities and aspects of antiplatelet therapy for stroke prevention.
Topics: Aspirin; Blood Platelets; Cilostazol; Clopidogrel; Drug Design; Drug Resistance; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Tetrazoles; Ticlopidine | 2006 |
Antiplatelet therapy after percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Tetrazoles; Ticlopidine; Time Factors | 2006 |
Use of ticlopidine and cilostazol after intracoronary drug-eluting stent placement in a patient with previous clopidogrel-induced thrombotic thrombocytopenic purpura: a case report.
Topics: ADAM Proteins; ADAMTS1 Protein; Aged; Apoptosis; Aspirin; Autoantibodies; Cilostazol; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Plasmapheresis; Platelet Aggregation Inhibitors; Purpura, Thrombotic Thrombocytopenic; Stents; Tetrazoles; Ticlopidine | 2006 |
[Three cases of internal carotid artery dissection due to trivial trauma].
Topics: Adolescent; Adult; Carotid Artery, Internal, Dissection; Cilostazol; Female; Fibrinolytic Agents; Humans; Magnetic Resonance Angiography; Neck Injuries; Tetrazoles; Ticlopidine | 2007 |
Antithrombotic therapy in peripheral arterial disease.
Topics: Anticoagulants; Aspirin; Atherosclerosis; Cilostazol; Clopidogrel; Comorbidity; Diabetic Angiopathies; Humans; Hypertension; Intermittent Claudication; Pentoxifylline; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Tetrazoles; Thrombolytic Therapy; Ticlopidine | 2008 |
Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease.
Topics: Alanine Transaminase; Animals; Aspirin; Cholesterol; Choline Deficiency; Cilostazol; Dietary Fats; Drug Evaluation, Preclinical; Fatty Liver; Humans; Liver Cirrhosis, Experimental; Male; Platelet Aggregation Inhibitors; Rats; Rats, Inbred F344; Tetrazoles; Ticlopidine; Treatment Outcome | 2008 |
[Perioperative management of patients with drug-eluting coronary stents presenting for non-cardiac surgery].
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cilostazol; Drug Administration Schedule; Drug-Eluting Stents; Female; Heparin; Humans; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Tetrazoles; Thrombosis; Ticlopidine; Time Factors | 2008 |
Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occlusion; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Electrocardiography; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Sirolimus; Tetrazoles; Ticlopidine; Ventricular Fibrillation | 2010 |
Oral triple antiplatelet therapy after percutaneous coronary intervention: subject with ongoing arguments?
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Restenosis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 2010 |
[Recurrent idiopathic cerebral infarction in a 5-year-old boy, with emphasis on the importance of platelet aggregation analysis for appropriate selection of anti-platelet drugs].
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Tests; Cerebral Infarction; Child, Preschool; Cilostazol; Collagen; Drug Therapy, Combination; Epinephrine; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Tetrazoles; Ticlopidine; Treatment Outcome | 2009 |
Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation.
Topics: Aspirin; Cellular Senescence; Cilostazol; Clopidogrel; Down-Regulation; Drug-Eluting Stents; Endothelium, Vascular; Everolimus; Humans; Immunosuppressive Agents; Nitric Oxide Synthase Type III; Oxidative Stress; Paclitaxel; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Sirolimus; Sirtuin 1; Sirtuins; Tetrazoles; Ticlopidine; Vasodilator Agents | 2009 |
Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Combined Modality Therapy; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Registries; Retrospective Studies; Tetrazoles; Ticlopidine | 2009 |
Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Disease; Drug Interactions; Drug Therapy, Combination; Drug-Eluting Stents; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome | 2009 |
Medical treatment of patients with intracranial atherosclerotic disease.
Topics: Anticoagulants; Aspirin; Atherosclerosis; Brain Ischemia; Cilostazol; Clopidogrel; Dipyridamole; Embolism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Intracranial Thrombosis; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Factors; Tetrazoles; Ticlopidine | 2009 |
Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats.
Topics: Animals; Aspirin; Brain Ischemia; Cells, Cultured; Cerebrovascular Circulation; Cilostazol; Clopidogrel; Endothelial Cells; Epoprostenol; Humans; Hypertension; Laser-Doppler Flowmetry; Male; Nitric Oxide; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred SHR; Tetrazoles; Ticlopidine | 2010 |
Antiplatelet therapy after coronary intervention in Asia and Japan: the Asian perspective of antiplatelet intervention.
Topics: Asia; Cerebral Hemorrhage; Cerebrovascular Disorders; Cilostazol; Clopidogrel; Coronary Disease; Europe; Humans; Liver; North America; Platelet Aggregation Inhibitors; Pyridines; Tetrazoles; Ticlopidine | 2009 |
Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Tetrazoles; Thrombosis; Ticlopidine; Time Factors | 2010 |
Antiplatelet therapy after percutaneous coronary intervention: Should another regimen be "TAPT?".
Topics: Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Chemotherapy, Adjuvant; Cilostazol; Clinical Trials as Topic; Clopidogrel; Contraindications; Cytochrome P-450 CYP2C19; Drug Interactions; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Proton Pump Inhibitors; Tetrazoles; Thrombosis; Ticlopidine | 2010 |
Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Registries; Stents; Tetrazoles; Thrombosis; Ticlopidine; Time Factors | 2010 |
Determination of the prevalence of aspirin and clopidogrel resistances in patients with coronary artery disease by using various platelet-function tests.
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Artery Disease; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Tetrazoles; Ticlopidine | 2010 |
Comparison of platelet P2Y(12) ADP receptor-mediated pathway inhibition in triple versus dual antiplatelet therapy as assessed by VASP-phosphorylation in Japanese patients undergoing coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Proteins; Cell Adhesion Molecules; Cilostazol; Clopidogrel; Diabetic Angiopathies; Female; Humans; Japan; Male; Microfilament Proteins; Middle Aged; Myocardial Infarction; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stents; Tetrazoles; Ticlopidine | 2010 |
What is the optimal duration of triple anti-platelet therapy in patients with acute myocardial infarction undergoing drug-eluting stent implantation?
Topics: Aspirin; Cilostazol; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Tetrazoles; Ticlopidine; Time Factors | 2011 |
What is the best first agent to give to a patient with acute ischaemic stroke? Aspirin, heparin, clopidogrel, cilostazol or dipyridamole?
Topics: Aspirin; Brain Ischemia; Cilostazol; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation Inhibitors; Stroke; Tetrazoles; Ticlopidine | 2010 |
Clopidogrel resistance and the effect of combination cilostazol in patients with ischemic stroke or carotid artery stenting using the VerifyNow P2Y12 Assay.
Topics: Aged; Blood Coagulation Tests; Blood Platelets; Carotid Artery Diseases; Cilostazol; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Secondary Prevention; Stents; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome | 2011 |
Optimizing of thienopyridine therapy by multiple electrode platelet aggregometry in clopidogrel low responders undergoing PCI.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Cerebrovascular Disorders; Cilostazol; Clopidogrel; Drug Monitoring; Drug Resistance; Drug Substitution; Electrodes; Female; Germany; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Stents; Tetrazoles; Thiophenes; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Beneficial effect of anti-platelet therapies on atherosclerotic lesion formation assessed by phase-contrast X-ray CT imaging.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Body Weight; Brachiocephalic Trunk; Cell Adhesion Molecules; Cholesterol, Dietary; Cilostazol; Clopidogrel; Collagen; Cytokines; Disease Models, Animal; Gene Expression Regulation; Immunohistochemistry; Inflammation Mediators; Lipids; Macrophages; Mice; Mice, Knockout; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Ticlopidine; Tomography, X-Ray Computed | 2012 |
Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Chi-Square Distribution; Cilostazol; Clopidogrel; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Registries; Republic of Korea; Risk Assessment; Risk Factors; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 2011 |
Impact of adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitus.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Cilostazol; Clopidogrel; Diabetes Mellitus, Type 2; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Tetrazoles; Thrombosis; Ticlopidine | 2012 |
Cilostazol to overcome high on-treatment platelet reactivity in korean patients treated with clopidogrel and calcium-channel blocker.
Topics: Calcium Channel Blockers; Cilostazol; Clopidogrel; Drug Antagonism; Female; Humans; Male; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine | 2011 |
Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy Accordin
Topics: Aged; Aryl Hydrocarbon Hydroxylases; Aspirin; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cilostazol; Clopidogrel; Cohort Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Regression Analysis; Tetrazoles; Ticlopidine | 2012 |
Post percutaneous coronary intervention antiplatelet therapy: current perceptions, prospects and perplexity.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Restenosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Metals; Patient Selection; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Tetrazoles; Thiophenes; Thrombosis; Ticlopidine; Treatment Outcome | 2011 |
A case of acute coronary artery occlusion associated with very rapid onset heparin-induced thrombosis without thrombocytopenia.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Aspirin; Autoantibodies; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occlusion; Drug Therapy, Combination; Female; Heart Failure; Heparin; Humans; Pipecolic Acids; Platelet Count; Platelet Factor 4; Stents; Sulfonamides; Tetrazoles; Thrombosis; Ticlopidine; Time Factors | 2012 |
Clinical and pathological improvement in stroke-prone spontaneous hypertensive rats related to the pleiotropic effect of cilostazol.
Topics: Animals; Aspirin; Biomarkers; Cerebral Infarction; Cilostazol; Clopidogrel; Hippocampus; Male; Nerve Tissue Proteins; Oxidative Stress; Platelet Aggregation Inhibitors; Rats; Rats, Inbred SHR; Receptor, IGF Type 1; Tetrazoles; Ticlopidine | 2012 |
[Resistance to antiplatelet agents assessed by a point-of-care platelet function test and thromboembolic adverse events in neurointervention].
Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Drug Resistance; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Tetrazoles; Thromboembolism; Ticlopidine | 2012 |
Pharmacodynamic effect of clopidogrel therapy and switching to cilostazol in patients with the CYP2C19 loss-of-function allele (ACCEL-SWITCH) study.
Topics: Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Asian People; Aspirin; Cilostazol; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Genotype; Heterozygote; Homozygote; Humans; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Republic of Korea; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2012 |
Pharmacodynamic effect of cilostazol plus standard clopidogrel versus double-dose clopidogrel in patients with type 2 diabetes undergoing percutaneous coronary intervention.
Topics: Cilostazol; Clopidogrel; Diabetes Mellitus, Type 2; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Tetrazoles; Ticlopidine | 2012 |
Combination of cilostazol and clopidogrel attenuates rat critical limb ischemia.
Topics: Animals; Blotting, Western; Cilostazol; Clopidogrel; Drug Therapy, Combination; Extremities; Flow Cytometry; Immunohistochemistry; Ischemia; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Tetrazoles; Ticlopidine | 2012 |
Reversible shortness of breath caused by the antiplatelet agent, clopidogrel.
Topics: Aspirin; Cilostazol; Clopidogrel; Dyspnea; Embolization, Therapeutic; Endovascular Procedures; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Ticlopidine | 2013 |
Triple antiplatelet therapy with cilostazol: hitting the "sweet-spot".
Topics: Aspirin; Blood Platelets; Cilostazol; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Tetrazoles; Ticlopidine | 2013 |
The impact of triple anti-platelet therapy for endothelialization and inflammatory response at overlapping bioabsorbable polymer coated drug-eluting stents in a porcine coronary model.
Topics: Absorbable Implants; Animals; Aspirin; Cilostazol; Clopidogrel; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug Therapy, Combination; Drug-Eluting Stents; Female; Inflammation; Neointima; Platelet Aggregation Inhibitors; Polymers; Swine; Tetrazoles; Ticlopidine; Treatment Outcome | 2013 |
Cilostazol for primary prevention of stroke in peripheral artery disease: a population-based longitudinal study in Taiwan.
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Cohort Studies; Female; Humans; Longitudinal Studies; Male; Peripheral Arterial Disease; Retrospective Studies; Risk Factors; Stroke; Taiwan; Tetrazoles; Ticlopidine; Vasodilator Agents | 2013 |
Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms.
Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Ticlopidine | 2013 |
Cilostazol--a forgotten antiplatelet agent, but does it even matter?
Topics: Cilostazol; Clopidogrel; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine | 2013 |
Cilostazol-based triple antiplatelet therapy in the era of generic clopidogrel and new potent antiplatelet agents.
Topics: Aspirin; Cilostazol; Clopidogrel; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine | 2014 |
Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
Topics: Aged; Angioplasty; Aspirin; Brain Ischemia; Carotid Stenosis; Cilostazol; Clopidogrel; Diffusion Magnetic Resonance Imaging; Drug Resistance; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Stents; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2014 |
Neurovascular protection of cilostazol in stroke-prone spontaneous hypertensive rats associated with angiogenesis and pericyte proliferation.
Topics: Animals; Antigens; Aspirin; Cerebrovascular Circulation; Cilostazol; Clopidogrel; Disease Models, Animal; Endothelium; Fibrinolytic Agents; Male; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Nerve Tissue Proteins; Pericytes; Proteoglycans; Rats; Rats, Inbred SHR; Stroke; Tetrazoles; Ticlopidine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Cilostazol; Dipyridamole; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Japan; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Secondary Prevention; Stroke; Succinates; Tablets, Enteric-Coated; Tetrazoles; Ticlopidine | 2014 |
Temporary adjunctive cilostazol vs clopidogrel loading for ST-segment elevation acute myocardial infarction.
Topics: Acute Disease; Aged; Cilostazol; Clopidogrel; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Tetrazoles; Ticlopidine | 2014 |
Prospective registry of carotid artery stenting in Japan--investigation on device and antiplatelet for carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Arteries; Carotid Stenosis; Cilostazol; Clopidogrel; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Humans; Japan; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 2014 |
Cilostazol in acute myocardial infarction: new tricks for an old drug?
Topics: Cilostazol; Clopidogrel; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine | 2014 |
Semi-mechanistic modelling and simulation of inhibition of platelet aggregation by antiplatelet agents.
Topics: Adult; Blood Platelets; Cilostazol; Clopidogrel; Half-Life; Humans; Models, Theoretical; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; Salicylates; Tetrazoles; Ticlopidine; Young Adult | 2014 |
Triple versus dual antiplatelet therapy after percutaneous coronary intervention for coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stent) II Registry.
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Republic of Korea; Retrospective Studies; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome | 2015 |
Levels and values of lipoprotein-associated phospholipase A2, galectin-3, RhoA/ROCK, and endothelial progenitor cells in critical limb ischemia: pharmaco-therapeutic role of cilostazol and clopidogrel combination therapy.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Base Sequence; Cilostazol; Clopidogrel; DNA Primers; Drug Therapy, Combination; Endothelial Progenitor Cells; Extremities; Female; Galectin 3; Humans; Ischemia; Male; Platelet Aggregation Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; Tetrazoles; Ticlopidine | 2014 |
Comparative effects of the anti-platelet drugs, clopidogrel, ticlopidine, and cilostazol on aspirin-induced gastric bleeding and damage in rats.
Topics: Animals; Aspirin; Cilostazol; Clopidogrel; Hemoglobins; Hemorrhage; Male; Peroxidase; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Stomach Diseases; Tetrazoles; Ticlopidine | 2014 |
Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy.
Topics: Aged; Aspirin; Atrial Fibrillation; Cilostazol; Clopidogrel; Databases, Factual; Female; Fibrinolytic Agents; Humans; Incidence; Intracranial Embolism; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Tetrazoles; Ticlopidine | 2015 |
Low-dose adjunctive cilostazol in patients with complex lesions undergoing percutaneous coronary intervention.
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Safety; Tetrazoles; Ticlopidine; Treatment Outcome | 2016 |
Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Diabetes Mellitus; Drug Resistance; Drug Therapy, Combination; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation; Platelet Aggregation Inhibitors; Premedication; Prospective Studies; Purinergic P2Y Receptor Antagonists; Smoking; Stents; Tetrazoles; Ticlopidine | 2016 |
It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting Stent.
Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Registries; Sirolimus; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome | 2015 |
Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database.
Topics: Aspirin; Cilostazol; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Hemorrhage; Humans; Insurance, Health; Korea; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Succinates; Tetrazoles; Ticlopidine; Treatment Outcome | 2016 |
Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Connective Tissue Diseases; Female; Fibrinolytic Agents; Heart Failure; Hemorrhage; Humans; Infections; Lung Diseases; Male; Middle Aged; Neoplasms; Pneumonia; Pulmonary Alveoli; Retrospective Studies; Survival Rate; Tetrazoles; Ticlopidine; Vasculitis; Warfarin | 2016 |
Outcome of Triple Antiplatelet Therapy Including Cilostazol in Elderly Patients with ST-Elevation Myocardial Infarction who Underwent Primary Percutaneous Coronary Intervention: Results from the INTERSTELLAR Registry.
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; ST Elevation Myocardial Infarction; Tetrazoles; Ticlopidine | 2017 |
[[Impact of plestazol preparation on hyperplasia of inter vascular layer in the patients, suffering obliterating atherosclerosis of the lower extremities arteries after reconstructive operations].]
Topics: Aged; Aged, 80 and over; Arteriosclerosis Obliterans; Biomarkers; Case-Control Studies; Cilostazol; Clopidogrel; Endothelium, Vascular; Female; Femoral Artery; Fibroblast Growth Factor 2; Humans; Hyperplasia; Intercellular Adhesion Molecule-1; Lower Extremity; Male; Middle Aged; Plastic Surgery Procedures; Popliteal Artery; Tetrazoles; Ticlopidine; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 2016 |
The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis.
Topics: Aged; Asian People; Aspirin; China; Cilostazol; Clopidogrel; Coronary Restenosis; Data Interpretation, Statistical; Drug Combinations; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Molecular Docking Simulation; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Tetrazoles; Ticlopidine | 2018 |
The safety of triple antiplatelet therapy under thromboelastography guidance in patients undergoing stenting for ischemic cerebrovascular disease.
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Stroke; Thrombelastography; Ticlopidine | 2019 |
Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease: Subanalysis of a Prospective Cohort.
Topics: Adult; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Cilostazol; Clopidogrel; Drug Substitution; Female; Humans; Male; Middle Aged; Moyamoya Disease; Multivariate Analysis; Oxygen Radioisotopes; Perfusion Imaging; Platelet Aggregation Inhibitors; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2018 |
CSPS.com Trial of Adding Cilostazol to Antiplatelet Therapy to Reduce Recurrent Stroke.
Topics: Aspirin; Cerebral Infarction; Cilostazol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Stroke; Ticlopidine | 2020 |
Cilostazol plus clopidogrel in the prevention of in-stent stenosis after vertebral artery origin stenting in gout patients: three case reports.
Topics: Aged; Brain Ischemia; Cilostazol; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination; Gout; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Vertebral Artery | 2020 |
Cost-Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke.
Topics: Aspirin; Cilostazol; Clopidogrel; Cost-Benefit Analysis; Humans; Markov Chains; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Secondary Prevention; Stroke; Ticlopidine | 2022 |
Comparison of Cilostazol versus Clopidogrel in Addition to Aspirin in Patients with Ischemic Stroke who Underwent Intracranial or Extracranial Artery Stent Implantation.
Topics: Arteries; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome | 2023 |
Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease.
Topics: Cilostazol; Diabetes Mellitus; Humans; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Retrospective Studies; Tetrazoles; Ticlopidine; Treatment Outcome | 2023 |
Differential inhibition of platelet function by cilostazol in combination with clopidogrel.
Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Tetrazoles; Ticlopidine | 2023 |